54th ENMC International Workshop: PROMM (Proximal Myotonic Myopathies) and Other Proximal Myotonic Syndromes 10-12th October 1997, Naarden, The Netherlands

Neuromuscular Disorders

Volumn 8, Issue 7, 1998, Pages 508-518

  Moxley III, Richard T ^a   Udd, Bjarne ^b   Ricker, Kenneth ^c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b VAASA CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; GENE MUTATION; HUMAN; INSULIN RESISTANCE; MOLECULAR GENETICS; MUSCLE BIOPSY; MYOTONIA; PRIORITY JOURNAL; TRINUCLEOTIDE REPEAT;

HISTORY, 20TH CENTURY; HUMANS; MYOTONIA; NEUROMUSCULAR DISEASES; SYNDROME;

EID: 0032191690     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00068-6     Document Type: Conference Paper

References (50)

1. [1] Brook JD, Mc Currach ME, Harley GH, et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3́ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
2. [2] Fu Y, Pizzuti A, Fenwick RG Jr, et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;225: 1256-1258.
3. [3] Mahadevan M, Tsilfidis C, Sabourin L, et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3́ untranslated region of the gene. Science 1992;225:1253-1255.
4. [4] Harper PS. Myotonic dystrophy, 2nd edn. London, WB Saunders, 1989.
5. [5] Ricker K, Koch M, Lehmann-Horn F, et al. Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994;44:1448-1452.
6. [6] Abdalla JA, Casley WL, Cousin HK, et al. Linkage of Thomsen disease to the T-cell receptor beta (TCRB) locus on chromosome 7q35. Am J Hum Genet 1992;51:579-584.
7. [7] McClatchey AI, Trofatter J, McKenna-Yasek D, et al. Dinucleotide repeat polymorphism at the SCN4A locus suggest allelic heterogeneity of hyperkalemic periodic paralysis and paramyotonia congenita. Am J Hum Genet 1992;50:896-901.
8. [8] Thornton CA, Griggs RC, Moxley III RT. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994;35:269-272.
9. [9] Lacomis D, Chad D, Smith T. Proximal weakness as the primary manifestation of myotonic dystrophy in older adults. Muscle Nerve 1994;17:687-688.
10. [10] Ricker K, Koch M, Lehmann-Horn F, et al. Proximal myotonic myopathy -clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995;52:25-31.
11. [11] Stoll G, von Giesen H-J, Koch M, et al. Proximal myotonic myopathy syndrome in the absence of trinucleotide repeat expansion. Muscle Nerve 1995;18:782-783.
12. [12] Hund E, Jansen O, Koch M, et al. Proximal myotonic myopathy with MRI white-matter abnormalities of the brain. Neurology 1997;48: 33-37.
13. [13] Meola G, Sansone V, Radice S, et al. A family with an unusual myotonic and myopathic phenotype and no CTG expansion (proximal myotonic myopathy syndrome): a challenge for future molecular studies. Neuromusc Disord 1996;6:143-150.
14. [14] Gomez J, Cervera C, Fernandez J, et al. Proximal myotonic myopathy report of three families. Neuromusc Disord 1996;Suppl. S46.
15. [15] Rowland LP. Thornton-Griggs-Moxley disease: myotonic dystrophy type 2. Ann Neurol 1994;36:803-804.
16. [16] Sander HW, Tavoulareas G, Chokroverty S. Heat-sensitive myotonia in proximal myotonic myopathy. Neurology 1996;47:956-962.
17. [17] Griggs R, Sansone V, Lifton A, Moxley III R. Hypothyroidism unmasking proximal myotonic myopathy (PROMM). Neurology 1997;48 Suppl):A267.
18. [18] Moxley III R, Sansone V, Lifton A, Thornton C. Insulin resistance in proximal myotonic myopathy (PROMM). Neurology 1997;48(Supp1):A229.
19. [19] Sansone V, Cappa S, Cotelli M, Rognon-e F, Thornton C, Moxley III R. Magnetic resonance imaging and cognitive alterations in proximal myotonic myopathy (PROMM). Neurology 1997;48(Suppl):A231.
20. [20] Abbruzzese C, Krahe R, Liguori M, et al. Myotonic dystrophy phenotype without expansion of (CTG)n repeat, distinct from proximal myotonic myopathy (PROMM). J Neurol 1996;243:715-721.
21. [21] Wicklein EM, Zülke C, Becker V, Schröder S, Gal A, Kunze K. Myotonia, severe facial, distal and proximal muscle dystrophy, cataract and frontal balding without CTG repeat expansion in the myotonic dystrophy gene. Eur J Neurol 1996;3 (Suppl 5):200.
22. [22] Udd B, Krahe R, Wallgren-Pettersson C, Falck B, Kalimo H. Proximal myotonic dystrophy - a family with proximal muscular dystrophy, myotonia, cataracts and hearing loss. Heterogeneity of proximal myotonic syndromes? Neuromusc Disord 1997;7:217-228.
23. [23] Moxley III RT. Proximal myotonic myopathy: mini-review of a recently delineated clinical disorder. Neuromusc Disord 1996;6: 87-93.
24. [24] Ptacek LJ, Johnson KJ, Griggs RC. Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993;328:482.
25. [25] Renaud JF. Involvement of cation transporting systems in myotonic diseases. Biochimie 1987;69:407-410.
26. [26] Renaud JF, Desnuell C, Schmid-Antomarchi H, Hughes M, Serratrice G, Lazdunski M. Expression of apamin receptor in muscles of patients with myotonic dystrophy. Nature (London) 1986;319:678-680.
27. + channels in myotonic dystrophy. Muscle Nerve 1994;17:2364-2370.
28. [28] Vergara C, Ramirez B, Behrens MI. Colchicine alters apamin receptors, electrical activity, and skeletal muscle relaxation. Muscle Nerve 1993;16:935-940.
29. + channels in skeletal muscle. Muscle Nerve 1996;19:331-337.
30. [30] Lehmann-Horn F, Engel AG, Ricker K, et al. Myology: the periodic paralysis and paramytonia congenita. Volume 2, 2nd edition. New York, McGraw-Hill, 1994: 1303-1334.
31. [31] Lehmann-Horn F, Rüdel R. Channelopathies: the non-dystrophic myotonias and periodic paralyses. Semin Pediatr Neurol 1996;3: 122.
32. [32] Barchi RL. Molecular pathology of the skeletal muscle soduim channel. Ann Rev Physiol 1995;57:355.
33. [33] Cannon SC. From mutation to myotonia in sodium channel disorders. Neuromusc Disord 1997;7:241.
34. [34] Rüdel R, Lehmann-Horn F, Ricker K. Altered excitability of the muscle cell membrane. The non-dystrophic myotonias. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill, 1994: 1291.
35. [35] Koch MC, Steinmeyer K, Lorenz C, et al. The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992;257:797.
36. [36] George AL, Crackower MA, Abdalla JA, et al. Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nature Genet 1993;3:305-310.
37. [37] Meyer-Kleine C, Steinmeyer K, Ricker K, et al. Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN 1) leading to myotonia. Am J Hum Genet 1995;57: 1325.
38. [38] Pusch M, Steinmeyer K, Koch MC, et al. Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel. Neuron 1995;15:1455.
39. [39] Zhang J, George AL, Griggs RC, et al. Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita. Neurology 1996;47:993.
40. [40] Koty PP, Pegoraro E, Hobson G, et al. Myotonia and the muscle chloride channel: dominant mutations show variable penetrance and founder effect. Neurology 1996;47:963.
41. [41] Fahlke C, Knittle T, Gurnett CA, et al. Subunit stoichiometry of human muscle chloride channels. J Gen Physiol 1997;109:93.
42. [42] Fahlke C, Beck CL, George AL. A mutation in autosomal dominant myotonia congenita affects pore properties of the muscle chloride channel. Proc Natl Acad Sci USA 1997;94:2729.
43. [43] Mailänder V, Heine R, Deymeer F, Lehmann-Horn F. Novel muscle chloride channel mutations and their effects on heterozygous carriers. Am J Hum Genet 1996;58:317-324.
44. [44] Lehmann-Horn F, Mailänder V, Heine R, George AL. Myotonia levior is a chloride channel disorder. Hum Mol Genet 1995;4: 1397-1402.
45. [45] Livingston JN, Moxley III RT. Myotonic dystrophy. Phenotype-genotype and insulin resistance. Diab Rev 1994;2:29-42.
46. [46] Glantz RH, Wright RB, Huckman MS, Garron DC, Siegel IM. Central nervous system magnetic resonance imaging findings in myotonic dystrophy. Arch Neurol 1989;45:36-37.
47. [47] Huber SJ, Kissel JT, Shuttleworth EC, Chakers DW, Clapp LE, Brogan MA. Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy. Arch Neurol 1989;46:536-537.
48. [48] Ranum LPW, Benzow KA, Lundgren JK, Koob MD, Day JW. A CTG repeat expansion detected by RED in a five generation kindred with a novel form of myotonic dystrophy. Am J Hum Genet 1996;59:A280.
49. [49] Schafling M, Hudson TJ, Buetow KH, Housinan DE. Direct detection of novel expanded trinucleotide repeats in the human genome. Nat Genet 1993;4:135-139.
50. [50] Thornton CA, Qiu-Ping Y, Sansone V, Lindblad K, Moxley III RT, Schalling M. No evidence that myotonic myopathy (PROMM) is associated with an expanded CTG/CAG repeat. Neurology, 1998, in press.